Your Source for Venture Capital and Private Equity Financings

Venture Capital News: GRO Biosciences Announces $25M Series A

2021-11-06
BOSTON, MA, GRO Biosciences closed a Series A financing totaling $25 million, co-led by Leaps by Bayer and Redmile Group.
GRO Biosciences Inc. (GRObio), an emerging biotechnology company, announced the closing of a Series A financing totaling $25 million co-led by Leaps by Bayer and Redmile Group.

The financing was joined by lead seed investors Digitalis Ventures, Innovation Endeavors and others bringing the total investment to $31.2 million.

GRObio's mission is to transform protein-based therapies for increasingly prevalent chronic medical conditions including autoimmune and metabolic diseases.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors